Wealth Effects Llc
Source: SEC Form 13F · as of Mar 2026Wealth Effects Llc holds 22 biotech & pharma companies tracked by BioSniper, totaling $23.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$23.7M
| Company | Shares | Value |
|---|---|---|
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 143,300 | $9.0M |
| ABBVAbbVie Inc. | 9,981 | $2.2M |
| PFEPFIZER INC | 76,075 | $2.1M |
| JNJJOHNSON & JOHNSON | 6,508 | $1.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,967 | $1.3M |
| MRKMerck & Co., Inc. | 9,814 | $1.2M |
| AMGNAMGEN INC | 2,750 | $968K |
| IBRXImmunityBio, Inc. | 118,350 | $908K |
| BMYBRISTOL MYERS SQUIBB CO | 13,875 | $842K |
| LLYELI LILLY & Co | 734 | $675K |
| PBIPROVENTION BIO, INC. | 61,000 | $674K |
| ABTABBOTT LABORATORIES | 5,824 | $598K |
| ALTAltimmune, Inc. | 131,950 | $406K |
| TGTXTG THERAPEUTICS, INC. | 12,000 | $399K |
| BEAMBeam Therapeutics Inc. | 10,100 | $241K |
| GLUEMonte Rosa Therapeutics, Inc. | 10,099 | $166K |
| CATXPerspective Therapeutics, Inc. | 33,000 | $138K |
| HUMAHumacyte Inc. | 204,500 | $124K |
| SCYXSCYNEXIS INC | 87,500 | $80K |
| OGNOrganon & Co. | 12,512 | $75K |
| AKBAAkebia Therapeutics, Inc. | 16,000 | $22K |
| AUTLAutolus Therapeutics plc | 10,000 | $14K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.